Skip to content

Covid-19 Virtual Recovery Study

Covid-19 Virtual Recovery Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04950725
Enrollment
2268
Registered
2021-07-06
Start date
2021-11-01
Completion date
2023-07-01
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

Respiratory muscle training, Covid-19, Long Hauler Syndrome, Long Covid, Nasal breathing

Brief summary

The purpose of this study is to determine the effects of respiratory muscle training (RMT) and nasal breathing on patients who have been infected with the SARS-CoV2 virus and continue to have lingering symptoms.

Detailed description

This study will be conducted virtually and will be completed at home using a cell phone application. Study participation involves the use of a RMT device, and/or nasal breathing. The purpose of this research is to evaluate the impact of RMT and nasal breathing on chronic symptoms of COVID-19 in patients that have recovered from SARS-CoV2. Subjects that have tested positive for the SARS-CoV2 infection and have completed a 14 to 30 day quarantine will be recruited.The RMT device will be used up to 2 times a day at a moderate intensity for 2 or 3 sets of 10 or 15 repetitions. Additionally, 2 sets of 10 nasal breathing techniques will be performed twice a day without the RMT device. Subjects will complete several surveys examining symptoms, physical activity, cognitive function, and quality of life at baseline, 2 weeks, and 4 weeks. Subjects will also perform phonation (speaking/speech sounds) and sit to stand tests at baseline, 2 weeks, and 4 weeks. All data will be collected through the use of a cell phone application. The cell phone application will also provide subjects with the proper RMT protocol. Additionally, subjects will receive coaching and instructions on how to use the breathing device, as well as instructions on how to complete the phonation and sit to stand test.

Interventions

BEHAVIORALStrength RMT

2 sets of 10 breaths twice per day using the breather or 3 sets of 10 breaths, twice per day using the Breather Fit

BEHAVIORALStrength RMT and nasal breathing

2 sets of 10 breaths twice per day using the Breather or 3 sets of 10 breaths twice per day using the Breather Fit. Subjects will also be asked to complete 2 sets of 10 nasal breathing exercises either before or after the RMT exercise.

BEHAVIORALEndurance RMT

15 breaths twice per day using the Breather or 20 breaths twice per day using the Breather Fit

BEHAVIORALEndurance RMT and nasal breathing

15 breaths twice per day using the Breather or 20 breaths twice per day using the Breather Fit at a lower intensity for a longer duration without break. Subjects will also perform 2 sets of 10 nasal breathing exercises either before or after the RMT exercise.

BEHAVIORALLow dose RMT

10 breaths, 3 times per week, at an intensity of 3 to 4 out of 10 using the Breather device.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Positive test for SARS-CoV2 within the last 3 months. * Smartphone user. * English speaker. * Age 18 or above. * US resident.

Exclusion criteria

* Hemodynamic instability. * Contraindications or inability to perform RMT. * Inability to navigate study questionnaires or tasks. * History of kidney disease, arteriosclerosis obliterans, and high calcium levels.

Design outcomes

Primary

MeasureTime frameDescription
Change in Phonation timechange from baseline to 4 weeksSpeaking/ speech sounds
Change in Sit to stand executionschange from baseline to 4 weeksHow many times an individual can go from sitting to standing in one minute
Change in number of reported COVID symptomschange from baseline to 4 weeksquestion asking to report presence of COVID-related symptoms
Change in breathing difficultychange from baseline to 4 weeksrating how difficult breathing is from 1 very difficult to 5 no difficulty at all
Change in reported affect of health on physical activitychange from baseline to 4 weeksrating of affect from 1 affects me severely to 5 not at all affected
Change in reported cognitionchange from baseline to 4 weekssummary score of memory, alertness, sadness, anxiety and focus getting better (1), worse (-1) or no change (0) where higher score equals more improvement

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026